Efficacy of glecaprevir and pibrentasvir treatment for genotype 1b HCV with drug resistance-associated variants in prior DAA treatment failures and human hepatocyte transplanted mice 1.Real-world efficacy of glecaprevir plus pibrentasvir for chronic hepatitis C patient with previous direct-acting antiviral therapy failures 2.Efficacy of glecaprevir and pibrentasvir treatment for genotype 1b hepatitis C virus drug resistance-associated variants in humanized mice

アクセス数 : 241
ダウンロード数 : 61

今月のアクセス数 : 0
今月のダウンロード数 : 0
File
k8170_1.pdf 183 KB 種類 : abstract
File
k8170_2.pdf 225 KB 種類 : abstract
Title ( eng )
Efficacy of glecaprevir and pibrentasvir treatment for genotype 1b HCV with drug resistance-associated variants in prior DAA treatment failures and human hepatocyte transplanted mice 1.Real-world efficacy of glecaprevir plus pibrentasvir for chronic hepatitis C patient with previous direct-acting antiviral therapy failures 2.Efficacy of glecaprevir and pibrentasvir treatment for genotype 1b hepatitis C virus drug resistance-associated variants in humanized mice
Title ( jpn )
直接作用型抗ウイルス薬治療不成功例とヒト肝細胞移植マウスにおける薬剤耐性変異を伴うジェノタイプ1b型C型肝炎ウイルスに対するグレカプレビル/ピブレンタスビル治療の有効性の研究 1.実臨床における直接作用型抗ウイルス薬治療不成功C型肝炎患者に対するグレカプレビル/ピブレンタスビルの有効性の検討 2.ヒト肝細胞移植マウスを用いた薬剤耐性変異を伴うジェノタイプ1b型C型肝炎ウイルスに対するグレカプレビル/ピブレンタスビル治療の有効性の検討
Creator
Oosawa Mitsutaka
Descriptions
内容の要旨, 審査の要旨
Language
eng
Resource Type doctoral thesis
Rights
(c) Japanese Society of Gastroenterology 2018
(c) 2019 The Authors
Access Rights open access
Source Identifier
Osawa, M., Imamura, M., Teraoka, Y. et al. Real-world efficacy of glecaprevir plus pibrentasvir for chronic hepatitis C patient with previous direct-acting antiviral therapy failures. J Gastroenterol 54, 291-296 (2019)
Journal of General Virology, 2019, Volume 100, Issue 7, 001268
[DOI] https://doi.org/10.1007/s00535-018-1520-9
[DOI] https://doi.org/10.1099/jgv.0.001268
Dissertation Number 甲第8170号
Degree Name
Date of Granted 2020-03-23
Degree Grantors
広島大学
Remark 全文は、出版社の規定によりリポジトリでの公開が認められておりませんので、関連情報URLをご覧下さい。